Loading...

Kavita Mishra, MD, MPH

Title(s)Associate Professor, Radiation Oncology
SchoolSchool of Medicine
Phone415-353-7173
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.D.2002 Medicine

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lu JE, Welch RJ, Mishra KK, Daftari IK, Park SS. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning. Eye (Lond). 2019 Jul 05. PMID: 31278380.
      View in: PubMed
    2. Daftari IK, Quivey JM, Chang JS, Mishra KK. Technical Note: Feasibility study of titanium markers in choroidal melanoma localization for proton beam radiation therapy. Med Phys. 2018 Mar; 45(3):1036-1039. PMID: 29377168.
      View in: PubMed
    3. Osmanovic S, Moisseiev E, Mishra KK, Daftari I, Moshiri A, Morse L, Park SS. Phase I/II Randomized Study of Proton Beam with Anti-Vascular Endothelial Growth Factor for Exudative Age-Related Macular Degeneration: One-Year Results. Ophthalmol Retina. 2017 May - Jun; 1(3):217-226. PMID: 31047424.
      View in: PubMed
    4. Polishchuk AL, Mishra KK, Weinberg V, Daftari IK, Nguyen JM, Cole TB, Quivey JM, Phillips TL, Char DH. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma. Int J Radiat Oncol Biol Phys. 2017 01 01; 97(1):91-97. PMID: 27838186.
      View in: PubMed
    5. Mishra KK, Daftari IK. Proton therapy for the management of uveal melanoma and other ocular tumors. Chin Clin Oncol. 2016 Aug; 5(4):50. PMID: 27558251.
      View in: PubMed
    6. Mishra KK, Chiu-Tsao ST, Orton CG. Point/Counterpoint. Particle therapy is ideal for the treatment of ocular melanomas. Med Phys. 2016 Feb; 43(2):631-4. PMID: 26843226.
      View in: PubMed
    7. Hrbacek J, Mishra KK, Kacperek A, Dendale R, Nauraye C, Auger M, Herault J, Daftari IK, Trofimov AV, Shih HA, Chen YL, Denker A, Heufelder J, Horwacik T, Swakon J, Hoehr C, Duzenli C, Pica A, Goudjil F, Mazal A, Thariat J, Weber DC. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):336-43. PMID: 27084651.
      View in: PubMed
    8. Mishra KK, Quivey JM, Daftari IK, Weinberg V, Castro JR, Phillips TL, Char DH. In Reply to Kamrava and McCannel. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):216-7. PMID: 26279045.
      View in: PubMed
    9. Mishra KK, Quivey JM, Daftari IK, Weinberg V, Cole TB, Patel K, Castro JR, Phillips TL, Char DH. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):376-83. PMID: 25841624.
      View in: PubMed
    10. Seider MI, Stewart PJ, Mishra KK, Damato BE. Uveal melanoma gene expression profile test result provided for uveal metastasis. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct; 45(5):441-2. PMID: 25153656.
      View in: PubMed
    11. Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters. Int J Radiat Oncol Biol Phys. 2013 Oct 01; 87(2):330-6. PMID: 23886415.
      View in: PubMed
    12. Chappell MC, Char DH, Cole TB, Harbour JW, Mishra K, Weinberg VK, Phillips TL. Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol. 2012 Aug; 154(2):227-232.e2. PMID: 22541662.
      View in: PubMed
    13. Daftari IK, Mishra KK, O'Brien JM, Tsai T, Park SS, Sheen M, Phillips TL. Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning. Med Phys. 2010 Oct; 37(10):5199-207. PMID: 21089753.
      View in: PubMed
    14. Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol. 2010 Oct; 100(1):121-7. PMID: 20221671.
      View in: PubMed
    15. Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol. 2006 Apr; 8(2):166-74. PMID: 16495375.
      View in: PubMed